baber/WOPTO huggingface dataset:
Patent CA-2779191-C (CA)
Title: Procede pour doser un composant a doser dans un specimen et kit de dosage
Inventor: KAWAMURA MIZUHO
IPC: G01N33/53
Filed: 2010-10-27
Granted: 2018-01-30
Abstract: La présente invention concerne un procédé pour doser un composant à doser qui est contenu dans un spécimen, de telle manière que le composant à doser, tel qu'un antigène, contenu dans le spécimen puisse être précisément dosé sans être affecté par la température de réaction, etc., et un kit de dosage. Le procédé pour doser un composant à doser est caractérisé en ce qu'il comprend : la réaction, en présence d'un alcanolamide d'acide gras, du composant à doser dans un spécimen avec un premier anticorps capable de se lier audit composant à doser ; puis la réaction avec un deuxième anticorps marqué, dans lequel un marqueur est lié à un deuxième anticorps capable de se lier au composant à doser, pour former un immunocomplexe comprenant le premier anticorps, le composant à doser et le deuxième anticorps marqué ; et la mesure de la quantité du marqueur dans l'immunocomplexe ainsi formé. Le kit de dosage pour doser un composant à doser dans un spécimen est destiné à être utilisé dans le procédé de dosage décrit ci-dessus.
Patent CA-2779622-C (CA)
Inventor: PAZART LIONEL HENRI
IPC: A61M5/172
Filed: 2010-10-29
Granted: 2018-10-23
Abstract: The invention relates to a secure system for the perfusion of a body liquid, enabling a final control of compatibility of a treatment with the patient and/or the medical situation previously diagnosed by a doctor, in a simple, efficient and energy-saving manner. To this end, the system according to the invention comprises: a fluidic circuit of a perfusion (100, 1000) comprising a perfusion catheter (101), a perfusion tubing (102, 1002) and a container (103, 1003) for the determined perfusion product to be perfused to a patient (B); a means (400) for taking a body liquid sample from a patient; a sampling container (303) provided with a means (300) for fluidic connection to the means (400) for taking the sample; a means (710, 721) of analysis and comparison (710, 721) of the body liquid taken and a sample (810) of the determined product; a means for fluidic connection between the analysis means and the sampling container; and a means (731) for controlling the flow of the perfusion product in the tubing, the analysis and comparison means transmitting information (Ic) for comparing the body liquid (302) taken and the determined product sample (810) to the flow control means.
Patent CA-2782007-C (CA)
Inventor: OSTERROTH FRANK
IPC: C07K16/24
Filed: 2010-11-30
Granted: 2018-07-24
Abstract: Provided is a humanized or chimeric antibody or fragment thereof capable of binding to interleukin-10 (IL-10), wherein said antibody or fragment thereof: (i) binds to the same region of IL-10 as the IL-10 receptor a (IL-I10Ra) and is not capable of binding IL-10 when the IL-10 is bound to the IL- 10 receptor; and (ii) binds to IL-10 in homodimeric form by binding a discontinuous epitope comprising residues of both monomers. Further provided are related products and methods involving the use of the antibody or fragment thereof.
Patent CA-2787288-C (CA)
Inventor: HUETT DETLEF
IPC: B32B27/08
Filed: 2011-01-26
Granted: 2017-12-12
Abstract: The invention relates to transparent multilayer biaxially oriented polyolefin films comprising a base layer and at least one outer matt covering layer, which contains at least two incompatible polymers and has a surface roughness of at least 2.0 µm. The covering layer contains a polydialkyl siloxane having a viscosity of 100,000 to 500,000 mm2/s. The surface of said covering layer is pre-treated by means of corona.
Patent CA-2788373-C (CA)
Title: Personal allowed number system
Inventor: GONGAWARE GRANT
IPC: H04M3/42
Filed: 2012-09-04
Granted: 2019-10-22
Abstract: A system and method for preventing or facilitating communications between individuals who reside in detention environments (such as e.g., prisons or correctional facilities) and individuals who are not in such detention environments using an automated authentication or verification.
Patent CA-2793338-C (CA)
Inventor: FRANCHET JEAN-MICHEL PATRICK MAURICE
IPC: F01D5/14
Filed: 2011-03-18
Granted: 2017-10-31
Abstract: The invention relates to a method for producing a metal insert for protecting a leading or trailing edge of a compressor vane of an aeronautical machine made of a composite material, by stamping sheets (1) and diffusion bonding between said sheets, characterised in that said method comprises the steps of: initially shaping the sheets by stamping in order to approximate said sheets to the shape of the suction side (1E) and the pressure side (1I) of said insert; producing a core (3) shaped like the inner cavity of the metal insert to be manufactured, one of the surfaces thereof reproducing the inner shape of the suction side of the insert and the other surface reproducing the inner shape of the pressure side of the insert; positioning said sheets around said core and securing the assembly; applying a vacuum and sealing the assembly by bonding; assembling the assembly by hot isostatic compression; cutting the assembly to extract the core (3) and separate the insert; producing the outer profile of the insert by a final machining step.
Patent CA-2793411-C (CA)
Title: Structure lamellaire hygroscopique
Inventor: TAKATORI JUNICHI
IPC: A61F13/53
Filed: 2011-03-10
Granted: 2017-05-09
Abstract: La présente invention concerne une structure lamellaire hygroscopique ayant une configuration selon laquelle une couche d'absorption comprenant une résine hygroscopique a été intercalée, depuis ses côtés supérieur et inférieur, entre des feuilles de non-tissé hydrophile, caractérisée en ce que la surface supérieure et/ou la surface inférieure de la structure lamellaire hygroscopique a/ont été gaufrée(s) et en ce que la structure lamellaire hygroscopique, lorsqu'une solution saline physiologique est absorbée dans la structure lamellaire hygroscopique en quantité de 4 litres par m2 de la structure lamellaire (4 l/m2), satisfait aux deux relations (A) et (B) suivantes : (A) le taux de gonflement par l'épaisseur (T2/T1) est de 2 ou plus et (B) la profondeur des sillons gaufrés gonflés [(T2-t2)/T2] est de 0,7 ou plus (T1 est l'épaisseur (mm) de la structure lamellaire hygroscopique avant absorption de solution saline physiologique, T2 est l'épaisseur (mm) de la structure lamellaire hygroscopique après absorption de la solution saline physiologique, et t2 est l'épaisseur (mm) des sillons gaufrés de la structure lamellaire hygroscopique après absorption de la solution physiologique). La structure lamellaire hygroscopique ne se déforme pas avant et après l'absorption de liquides et présent une capacité d'absorption de liquides suffisante, comme d'excellentes propriétés d'infiltration de liquides et peu de fuites de liquide.
Patent CA-2796171-C (CA)
Title: Method and means for identifying substances which inhibit ige production
Inventor: JESSBERGER ROLF
IPC: G01N33/50
Filed: 2011-04-14
Granted: 2015-12-15
Abstract: The invention relates to the field of biomedical and pharmacological research, in particular to the area of immunology, allergies and autoimmune diseases. The inventors have shown that SWAP-70 is a higher-level regulator for STAT-6 and BCL-6, the regulator being specific for IgE production in B-cells by amplifying the effect of STAT-6 and antagonizing the effect of BCL-6. The inventors have observed no influence of SWAP-70 on the expression of other genes that are likewise regulated by STAT-6 and/or BCL-6. In summary, it can be concluded that SWAP-70 positively regulates IgE production by shifting the interaction of the two antagonists STAT-6 and BCL-6 with regulatory elements of the IgE gene in favor of the activator STAT-6. Based on said findings, the invention provides a screening method which allows for identifying novel active agents that specifically inhibit IgE production. The substances identified by the method according to the invention are particularly suited for treating IgE-induced allergies and IgE-dependent autoimmune diseases.
Patent CA-2796185-C (CA)
Inventor: BURRIS CHARLES
IPC: E05F3/10
Filed: 2011-04-15
Granted: 2015-12-08
Abstract: A door closer comprises a piston cooperating with a rotating pinion. Upon rotation of the pinion in the door opening direction, the piston moves toward the second end of the housing forcing fluid from a second variable volume chamber through a passage to a first variable volume chamber and compressing a spring assembly for storing energy. The spring assembly urges the piston toward the first end of the housing for forcing fluid from the first variable volume chamber to the second variable volume chamber and rotating the pinion in the door closing direction. A controller controls the position of a valve in the passage based on the sensed angular position of a door and the position of the valve for determining the amount of hydraulic fluid flowing through the valve.
Patent CA-2797719-C (CA)
Title: Small molecule inhibitors of usp1 deubiquitinating enzyme activity
Inventor: D'ANDREA ALAN D
IPC: A61P35/00
Filed: 2011-04-29
Granted: 2019-11-26
Abstract: Provided are small molecule inhibitors of ubiquitin specific protease 1 (USP1) activity and methods for their use in treating and characterizing cancers. The small molecule USP1 inhibitors of the invention are particularly useful in the treatment of cancers that are resistant to DNA cross-linking agents.
Patent CA-2799972-C (CA)
Title: Piperidinone derivatives as mdm2 inhibitors for the treatment of cancer
Inventor: BARTBERGER MICHAEL DAVID
IPC: C07D407/04
Filed: 2011-06-03
Granted: 2020-08-25
Abstract: The present invention provides MDM2 inhibitor compounds of Formula (I), wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.
Patent CA-2800941-C (CA)
Inventor: ESCOTT ADRIAN EDWARD
IPC: H04L29/06
Filed: 2011-06-16
Granted: 2018-03-27
Abstract: An authentication method is provided between a device (e.g., a client device or access terminal) and a network entity. A removable storage device may be coupled to the device and stores a subscriber-specific key that may be used for subscriber authentication. A secure storage device may be coupled to the device and stores a device-specific key used for device authentication. Subscriber authentication may be performed between the device and a network entity. Device authentication may also be performed of the device with the network entity. A security key may then be generated that binds the subscriber authentication and the device authentication. The security key may be used to secure communications between the device and a serving network.
Patent CA-2801896-C (CA)
Inventor: SANDINO ANA MARIA
IPC: A61P31/14
Filed: 2010-06-08
Granted: 2015-08-11
Abstract: The invention relates to a novel oral veterinary composition for salmonids, comprising 1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide and to the use thereof for the treatment of infectious salmon anaemia (ISA) caused by the infectious salmon anaemia or ISA virus in salmonids.
Patent CA-2804128-C (CA)
Inventor: KADEREIT DIETER
IPC: C07D498/04
Filed: 2011-01-12
Granted: 2017-12-12
Abstract: The invention relates to oxazolopyrimidine compounds of formula I, where A, R1, R2, R3, X and Y are defined as stated in the claims. The compounds of formula I are suitable, for example, for wound healing.
Patent CA-2806548-C (CA)
Inventor: BACKHOLM ARI
IPC: H04W24/02
Filed: 2011-07-08
Granted: 2015-03-31
Abstract: Systems and methods for distributed implementation of dynamic wireless traffic policy are disclosed. In one aspect, embodiments of the present disclosure include a system for optimizing resources in a mobile network having a local proxy on a mobile device to aggregate client-side parameters and a proxy server to aggregate server-side parameters. The local proxy and the proxy server can each communicate the client-side parameters and the server-side parameters, respectively, to the other component, to formulate a policy for traffic control in the mobile network between the mobile device and the server. The policy can be jointly implemented by the local proxy and the proxy server and dynamically adjusted in real-time.
Patent CA-2807155-C (CA)
Inventor: TRINH TU TIEN
IPC: E21B47/00
Filed: 2011-08-08
Granted: 2017-08-29
Abstract: A drill pipe made according to one embodiment includes a number of serially connected tubulars with a communication device placed between the connecting ends of the tubulars, wherein the communication device provides a direct data communication link between the adjoining tubulars.
Patent CA-2809553-C (CA)
Title: Imidazo[4,5-c]quinoleines utilisees comme inhibiteurs de l'adn-pk
Inventor: FUCHSS THOMAS
IPC: C07D215/44
Filed: 2011-07-26
Granted: 2019-02-26
Abstract: L'invention concerne des composés des formules (I) et (II) dans lesquelles R1, R2, R3, R4, R5, R8, X et m ont la signification indiquée dans les revendications, et/ou leurs sels, tautomères et stéréoisomères physiologiquement acceptables, y compris leurs mélanges dans toutes proportions. Les composés de la formule (I) peuvent être utilisés pour l'inhibition de protéines sérine-thréonine kinases ainsi que pour la sensibilisation de cellules cancéreuses vis-à-vis d'agents anticancéreux et/ou d'un rayonnement ionisant. L'invention concerne également l'utilisation des composés de formule (I) dans la prophylaxie, la thérapie ou le contrôle de l'évolution de cancers, de tumeurs, de métastases ou de troubles de l'angiogenèse, en combinaison avec une radiothérapie et/ou un agent anticancéreux. L'invention concerne également un procédé de fabrication des composés de formule (I) par réaction de composés de formule (II) et éventuellement conversion d'une base ou d'un acide des composés de formule (I) en un de leurs sels.
Patent CA-2810520-C (CA)
Title: Choix de la taille de l'adn pour l'analyse de la chromatine
Inventor: OKINO STEVEN
IPC: C40B40/06
Filed: 2011-09-09
Granted: 2019-03-12
Abstract: Procédés pour analyser l'ADN chromosomique, dont la chromatine. Methods for analyzing chromosomal DNA, including chromatin, are provided.
Patent CA-2812288-C (CA)
Inventor: DIPPEL JEFFERY JOHN PAUL
IPC: G06F3/041
Filed: 2011-09-23
Granted: 2016-12-13
Abstract: L'invention porte sur un procédé qui consiste à détecter un contact au niveau d'une pluralité de positions de contact sur un dispositif d'affichage tactile d'un dispositif électronique, à identifier quand le contact est un premier type de geste sur la base d'attributs de contact comprenant une première position de contact de la pluralité de positions de contact et au moins un élément parmi une vitesse du contact, un laps de temps entre la détection du contact au niveau de positions consécutives parmi les positions de contact, une distance entre les positions consécutives parmi les positions de contact et une direction du contact.
Patent CA-2818093-C (CA)
Inventor: COLLIN YANNICK
IPC: F01D5/22
Filed: 2011-11-21
Granted: 2018-08-28
Abstract: Turbomachine rotor blade having at its distal end a root with a platform having first and second opposite lateral edges (21, 22) and upstream and downstream sealing wipers (31, 32). Each of the first and second lateral edges (21, 22) has, between the upstream and downstream wipers (31, 32), a substantially Z-shaped profile. The root comprises, on the same side as the first lateral edge (21), a first, outwardly projecting rim (41) which is not connected to any one of the upstream and downstream wipers (31, 32). The root comprises a second outwardly projecting rim (42), this second rim (42) comprising a downstream part (44) connected to the downstream wiper (32) and which extends along the second lateral edge (22), and an upstream part (43) extending the downstream part (44) as far as the upstream wiper (31) and situated set back from the second lateral edge (22).
Patent CA-2818388-C (CA)
Inventor: PASQUERO JEROME
IPC: H04W4/029
Filed: 2013-06-11
Granted: 2018-02-27
Abstract: A device, system and method are provided for creation, accessing, and management of data items on a computing device, such as a mobile device, using physically-defined spatial relationships between the data items and the user. At least one of a tracking user interface and a kinetic user interface is used to determine the physical location of the mobile device with respect to the user, rather than with reference to a geographic location. Using one or both of these interfaces, individual data items may be associated with a location in the physical space surrounding the user. Data items may also be associated with a particular characteristic, such as a category or tag, based on its associated location. Data items may be subsequently retrieved by holding the mobile device in the physical space surrounding the user, then identifying those data items having an associated location proximate to the mobile device location.
Patent CA-2818931-C (CA)
Inventor: MYERS GARRY
IPC: A23L33/15
Filed: 2011-10-28
Granted: 2018-12-11
Abstract: La présente invention concerne un procédé d'analyse et de détermination d'une taille de dose adéquate dans des films à ingérer afin de permettre l'administration d'une dose plus précise d'un principe actif.
Patent CA-2819161-C (CA)
Title: Data returned responsive to executing a start subchannel instruction
Inventor: SZWED PETER KENNETH
IPC: G06F13/12
Filed: 2012-05-25
Granted: 2019-12-03
Abstract: Provided is a method of executing a Start Subchannel instruction in a computing environment comprising main storage and storage class memory, said method comprising: responsive to determining that a subchannel identified by the Start Subchannel instruction is an Asynchronous Data Mover (ADM) subchannel, performing: obtaining an operation request block from main storage, the operation request block comprising an address of an operation block; based on the address of the operation block, obtaining the operation block from main storage, the operation block consisting of a request block, a response block, and one or more first move specification blocks (MSBs), wherein the request block comprises an MSB count field having a value indicating the number of one or more MSBs included in and referenced by the operation block, wherein the response block is configured to hold exception conditions, wherein each move specification block is configured to include an operation code field, a block count field, a main storage address field for addressing main storage, a storage class memory address field for addressing storage class memory, a block size field and a flags field; obtaining a move specification block of the one or more move specification blocks; determining based on the operation code in the obtained move specification block an operation that the obtained move specification block is configured to perform on blocks of storage class memory; based on the move specification block, initiating the operation on the blocks of storage class memory associated with a storage class memory address of the storage class memory address field; and responsive to at least initiating the operation and encountering an exception condition, storing information within the response block, wherein the response block comprises an exception flags field, a field validity field, a failing MSB address field, a failing indirect data address word (AIDAW) address field, a failing main storage address field and a failing storage class memory address field, the information relating to one or more exceptions resulting from the operation, wherein the one or more exceptions are related to at least one of: main storage associated with a main storage address of the main storage address field, storage class memory associated with a storage class memory address of the storage class memory address field, or the obtained move specification block, and wherein the information includes an indication of an exception and additional information relating to the exception, the additional information specifying one or more address exceptions.
Patent CA-2822536-C (CA)
Inventor: BARTOLUCCI JEAN-CHARLES
IPC: C12N1/18
Filed: 2011-12-09
Granted: 2019-04-09
Abstract: The subject matter of the present invention is novel broad-spectrum bread yeast strains, i.e. yeast strains which are effective both on "sugar-free" doughs and "sweetened" doughs. The subject matter of the present invention is also yeasts obtained by culturing said yeast strains and the use thereof in breadmaking. The subject matter of the invention is also a method for obtaining broad-spectrum yeast strains.
Patent CA-2824122-C (CA)
Title: Gate retention for an inductor box of an agricultural implement
Inventor: JOHNSON CHAD M
IPC: A01C7/20
Filed: 2013-08-21
Granted: 2018-07-17
Abstract: An inductor box for an agricultural implement includes an inlet configured to receive agricultural product from a tank. The inductor box also includes a housing having a cavity therein. The cavity is configured to receive the agricultural product from the inlet. The inductor box includes a gate configured to be removably inserted between the inlet and the cavity, to block the agricultural product from entering the cavity while disposed between the inlet and the cavity, and to enable the agricultural product to enter the cavity while removed from being disposed between the inlet and the cavity. The inductor box includes a first guide coupled to the housing and configured to direct the gate away from the inlet. The first guide is disposed between the gate and the inlet while the gate is disposed between the inlet and the cavity.
Patent CA-2830103-C (CA)
Title: Microfluidic system having monolithic nanoplasmonic structures
Inventor: MALIC LIDIJA
IPC: G01N21/77
Filed: 2012-03-12
Granted: 2020-03-24
Abstract: A microfluidic system, particularly suited as a cell culture system, is provided having a single monolithic biocompatible substrate with both a surface having an ordered array of nano-scale elements required for plasmonic response monitoring and a network of microchannels for precisely controlling cellular environment. The system has the additional advantages of low-volume consumption, rapid low-cost fabrication of molds with easily interchangeable microfluidic channel layouts, amenability to mass production, and in situ label-free real-time detection of cellular response, viability, behavior and biomolecular binding using plasmonic techniques. A ratio of greater than 0.2 between the cross-sectional dimension and the spacing distance of the nano-scale elements is useful for plasmonic response monitoring. A process for producing such a system involves fabrication of a master mold containing the nano-scale elements etched into a hard substrate, and the micro-scale and meso-scale features, such as channels and chambers, provided in a soft membrane bonded to the hard substrate. A stamp may be created by setting a settable liquid polymer or metal placed in the master mold and then the features of the intended device transferred to a polymeric substrate using the stamp.
Patent CA-2835499-C (CA)
Inventor: OUELLETTE BENOIT
IPC: G05G1/00
Filed: 2011-05-12
Granted: 2019-12-24
Abstract: A controller includes a first body portion, adapted to be grasped by a persons middle finger, ring finger, and pinky finger, a second body portion adapted to be grasped by a persons index finger, and a third body portion that defines a first surface adapted to receive a persons thumb. A finger switch is positioned on a front surface of the second body portion. The finger switch is positioned such that it may be actuated by the persons index finger. The second body portion is disposed between the first body portion and the third body portion. The second body portion defines an offset with respect to the first body portion. The third body portion defines a second surface above the finger switch, which may receive the persons index finger.